ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Cyano-Mediated Donor-Acceptor Engineering: A Rational Strategy to Boost Charge Transfer in Carbon Dots for NIR-II Bioimaging.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Carbon dots (CDs) have emerged as an important class of probes for biomedical imaging. However, engineering CDs with near-infrared emission, especially in the second near-infrared window (NIR-II), remains a significant challenge. Herein, we propose a cyano-mediated donor-acceptor (D-A) engineering strategy to synthesize NIR-II emissive CDs (FC-CDs), using benzene-1,2,4,5-tetracarbonitrile, a molecule rich in electron-withdrawing cyano groups, as the precursor. Meanwhile, the in situ introduction of folic acid (FA) during the solvothermal process facilitates enhanced biocompatibility and tumor-targeting ability. The cyano groups on FC-CDs enable the formation of a unique D-A configuration, in which the carbon core acts as the electron donor and the electron-withdrawing-groups-functionalized surface serves as the electron acceptor. Experimental and theoretical evidence suggests that this D-A structure facilitates efficient intramolecular charge transfer and narrows the optical bandgap, both of which are key to achieving NIR-II emission. Thanks to the good biocompatibility and NIR-II characteristics, the performance of FC-CDs in in vivo NIR-II bioimaging (e.g., angiography, hepatic ischemia-reperfusion monitoring, and tumor-targeted imaging) has been verified. This cyano-mediated D-A engineering strategy thus provides insights into designing NIR-II emissive CDs for biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.